✦ LIBER ✦

The maladaptive effects of HIV protease inhibitors (lopinavir/ritonavir) on the rat heart

✍ Scribed by Reyskens, Kathleen M.S.E.; Essop, M. Faadiel

Book ID: 123071319
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 430 KB
Volume: 168
Category: Article
ISSN: 0167-5273
DOI: 10.1016/j.ijcard.2013.04.128

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetic Interactions Between the

Pharmacokinetic Interactions Between the Hepatitis C Virus Protease Inhibitor Boceprevir and Ritonavir-Boosted HIV-1 Protease Inhibitors Atazanavir, Darunavir, and Lopinavir

✍ Hulskotte, E. G. J.; Feng, H.-P.; Xuan, F.; van Zutven, M. G. J. A.; Treitel, M. 📂 Article 📅 2012 🏛 University of Chicago Press 🌐 English ⚖ 195 KB

Modeling Metabolic Effects of the HIV Pr

Modeling Metabolic Effects of the HIV Protease Inhibitor Ritonavir In Vitro

✍ Jeffrey Laurence; Rozbeh Modarresi; Xinwen Wang; Qizhi Yao; Changyi Chen 📂 Article 📅 2007 🏛 American Society for Investigative Pathology 🌐 English ⚖ 48 KB

Metabolism and Disposition of the HIV-1

Metabolism and Disposition of the HIV-1 Protease Inhibitor Lopinavir (ABT-378) Given in Combination with Ritonavir in Rats, Dogs, and Humans

✍ Gondi N. Kumar; Venkata K. Jayanti; Marianne K. Johnson; John Uchic; Samuel Thom 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 121 KB

Novel Heterocyclic Analogues of the HIV-

Novel Heterocyclic Analogues of the HIV-1 Protease Inhibitor, Ritonavir.

✍ Perry T. Kaye; Musiliyu A. Musa; Aloysius T. Nchinda; Xolani W. Nocanda 📂 Article 📅 2004 🏛 John Wiley and Sons ⚖ 21 KB 👁 1 views

The Effect of Lopinavir/Ritonavir on the

The Effect of Lopinavir/Ritonavir on the Renal Clearance of Tenofovir in HIV-infected Patients

✍ Kiser, JJ; Carten, ML; Aquilante, CL; Anderson, PL; Wolfe, P; King, TM; Delahunt 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 205 KB

Management of drug-to-drug interactions

Management of drug-to-drug interactions between cyclosporine A and the protease-inhibitor lopinavir/ritonavir in liver-transplanted HIV-infected patients

✍ Martin Vogel; Esther Voigt; Hans-Christoph Michaelis; Thomas Sudhop; Martin Wolf 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB 👁 1 views

Highly active antiretroviral therapy (HAART) has improved the life expectancy of HIV-infected patients, allowing orthotopic liver transplantation as a reasonable treatment option for selected patients with terminal liver disease. Both non-nucleoside reverse transcriptase inhibitors and protease inhi